AXL inhibition represents a novel therapeutic approach in BCR-ABL negative myeloproliferative neoplasms - Beitzen-Heineke, Antonia; Berenbrok, Nikolaus; Waizenegger, Jonas S.; Paesler, Sarina; Gensch, Victoria; Udonta, Florian; Vargas Delgado, Maria Elena; Engelmann, Janik; Hoffmann, Friederike; Schafhausen, Philippe; Amsberg, Gunhild von; Riecken, Kristoffer; et al. (HemaSphere, 2021)